Lite Strategy (LITS) Price to Book (2011 - 2026)
Lite Strategy (LITS) posted Price to Book of 0.72 for Q1 2026, up 22.36% on a QoQ basis from 0.59 in Q4 2025, and down 3.91% year-over-year from 0.75 in Q1 2025.
Analysis
Lite Strategy (LITS) Price to Book (2011 - 2026) Analysis & Trends
Lite Strategy has reported Price to Book for 16 years, with the latest figure at 0.72 in Q1 2026.
- On a quarterly basis, Price to Book fell 3.91% year-over-year to 0.72 in Q1 2026; TTM through Mar 2026 was 0.72, a 3.91% decrease from a year earlier, with the FY2025 full-year figure at 0.97, up 65.54% from the prior year.
- Price to Book was 0.72 for Q1 2026 at Lite Strategy, up from 0.59 in the prior quarter.
- The five-year high for Price to Book was 1.78 in Q2 2023, with the low at 0.52 in Q1 2024.
- Average Price to Book over 5 years is 0.88, with a median of 0.74 recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: Price to Book sank 86.34% in 2022, then jumped 65.54% in 2025.
- Over 5 years, Price to Book stood at 0.66 in 2022, then fell by 1.74% to 0.65 in 2023, then advanced by 14.18% to 0.74 in 2024, then declined by 20.94% to 0.59 in 2025, then increased by 22.36% to 0.72 in 2026.
- The last three Price to Book figures came in at 0.72 (Q1 2026), 0.59 (Q4 2025), and 0.64 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Lite Strategy | 38.03 Mn | 30.49 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 0.72 |
| Dec 31, 2025 | 0.59 |
| Sep 30, 2025 | 0.64 |
| Jun 30, 2025 | 0.97 |
| Mar 31, 2025 | 0.75 |
| Dec 31, 2024 | 0.74 |
| Sep 30, 2024 | 0.76 |
| Jun 30, 2024 | 0.59 |
| Mar 31, 2024 | 0.52 |
| Dec 31, 2023 | 0.65 |
| Sep 30, 2023 | 0.57 |
| Jun 30, 2023 | 1.78 |
| Mar 31, 2023 | 0.89 |
| Dec 31, 2022 | 0.66 |
| Sep 30, 2022 | 1.39 |
| Jun 30, 2022 | 1.55 |
| Mar 31, 2022 | 1.18 |
| Dec 31, 2021 | 4.84 |
| Sep 30, 2021 | 9.07 |
| Jun 30, 2021 | 6.49 |